THE IMPACT OF PD-1+ INNATE-LIKE CD8+T CELLS ON THE HBSAG REDUCTION IN ACTIVE CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T) IDE ANALOGUE THERAPY

被引：0
|
作者：
Jeng, Rachel Wen-Juei [1 ]
Huang, Hsiang-Wei [1 ]
Lin, Chia-Wei [1 ]
Fan, Jian He [1 ]
Liu, Yen-Chun [1 ]
Ku, Wei-Ting [1 ]
Wu, Cheng-Heng [1 ]
Huang, Chien-Hao [2 ]
Lin, Yung-Chang [1 ]
Lin, Chun Yen [1 ]
机构：
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan
[2] Chang Gung Univ, Taoyuan, Taiwan
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
996
引用
收藏
页码：S755 / S756
页数：2
相关论文
共 50 条
  • [21] Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
    Papatheodoridis, George V.
    Lampertico, Pietro
    Manolakopoulos, Spilios
    Lok, Anna
    JOURNAL OF HEPATOLOGY, 2010, 53 (02) : 348 - 356
  • [22] INTERRUPTION OF NUCLEOS(T)IDE ANALOGUE THERAPY FOR HBeAg-NEGATIVE CHRONIC HEPATITIS B - A NEW CONCEPT TO ACHIEVE HBsAg DECLINE?
    Siederdissen, C. Hoener Zu
    Rinker, F.
    Falk, C.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Mix, C.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A.
    Cornberg, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S571 - S572
  • [23] PROGRESSIVE DECLINE OF HBsAg TITERS IN LONG-TERM VIROLOGICAL RESPONDERS TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B
    Iavarone, M.
    Lampertico, P.
    Vigano, M.
    Facchetti, F.
    Lunghi, G.
    Melotti, S.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S331 - S331
  • [24] PROGRESSIVE DECLINE OF HBSAG TITERS IN LONG-TERM VIROLOGICAL RESPONDERS TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B
    Iavarone, Massimo
    Lampertico, Pietro
    Vigano, Mauro
    Facchetti, Floriana
    Melotti, Silvia
    Lunghi, Giovanna
    Colombo, Massimo
    HEPATOLOGY, 2008, 48 (04) : 709A - 709A
  • [25] Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
    Zoutendijk, Roeland
    Hansen, Bettina E.
    van Vuuren, Anneke J.
    Boucher, Charles A. B.
    Janssen, Harry L. A.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (03): : 415 - 418
  • [26] RETRACTION: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
    Sun, H.
    Liu, Y.
    Zhang, Y.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [27] Finite nucleos(t)ide analogue therapy in hepatitis Be antigen-negative chronic hepatitis B: From an "option" to an "active recommendation"
    Liaw, Yun-Fan
    Chien, Rong-Nan
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (04): : 295 - 301
  • [28] HBV PGRNA DYNAMICS CHARACTERISTICS AMONG CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUE TREATMENT.
    Luo, Hao
    Xu, Jinghang
    Cheng, Ran
    Han, Yifan
    Kang, Qian
    Tan, Ning
    Pan, Jiali
    Chen, Hongyu
    Yang, Yuqing
    Xu, Xiaoyuan
    HEPATOLOGY, 2020, 72 : 442A - 443A
  • [29] Tenofovir rescue therapy after multiple nucleos(t)ide analogue treatment failure in chronic hepatitis B patients
    Kim, Hyo Jin
    Cho, Ju-Yeon
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    Lee, Joon Hyeok
    HEPATOLOGY, 2013, 58 : 638A - 638A
  • [30] Letter: Consensus in international guidelines when discontinuing nucleos(t)ide analogue therapy in patients with chronic hepatitis B
    Trinh, Steven
    Andrew, Bridgette
    Bloom, Stephen
    Sawhney, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (09) : 954 - 955
12345